{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:55:29Z","timestamp":1768208129631,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006210","name":"Workforce Development for Teachers and Scientists","doi-asserted-by":"publisher","award":["2025-VSE"],"award-info":[{"award-number":["2025-VSE"]}],"id":[{"id":"10.13039\/100006210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10787-023-01341-7","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T13:01:46Z","timestamp":1695992506000},"page":"885-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0860-4445","authenticated-orcid":false,"given":"Pavlo","family":"Petakh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iryna","family":"Kamyshna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr","family":"Kamyshnyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"1341_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.622262","volume":"12","author":"B Bai","year":"2021","unstructured":"Bai B, Chen H (2021) Metformin: a novel weapon against inflammation. Front Pharmacol 12:622262","journal-title":"Front Pharmacol"},{"key":"1341_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.784459","author":"CJ Bailey","year":"2022","unstructured":"Bailey CJ, Gwilt M (2022) Diabetes, metformin and the clinical course of Covid-19: outcomes, mechanisms and suggestions on the therapeutic use of metformin. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.784459","journal-title":"Front Pharmacol"},{"issue":"1","key":"1341_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","volume":"42","author":"J Blagih","year":"2015","unstructured":"Blagih J, Coulombe F, Vincent EE, Dupuy F, Galicia-V\u00e1zquez G, Yurchenko E, Raissi TC, van der Gerritje JW, Windt BV, Pearce EL, Pelletier J, Piccirillo CA, Krawczyk CM, Divangahi M, Jones RG (2015) The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity 42(1):41\u201354","journal-title":"Immunity"},{"issue":"3","key":"1341_CR4","doi-asserted-by":"publisher","first-page":"F588","DOI":"10.1152\/ajprenal.00472.2010","volume":"301","author":"CL Buller","year":"2011","unstructured":"Buller CL, Heilig CW, Brosius FC 3rd (2011) GLUT1 enhances mTOR activity independently of TSC2 and AMPK. Am J Physiol Renal Physiol 301(3):F588-596","journal-title":"Am J Physiol Renal Physiol"},{"key":"1341_CR5","doi-asserted-by":"publisher","DOI":"10.3892\/or.2022.8266","author":"N Chen","year":"2022","unstructured":"Chen N, Zhou YS, Wang LC, Huang JB (2022) Advances in metformin-based metabolic therapy for non-small cell lung cancer (Review). Oncol Rep. https:\/\/doi.org\/10.3892\/or.2022.8266","journal-title":"Oncol Rep"},{"issue":"5","key":"1341_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri3198","volume":"12","author":"H Chi","year":"2012","unstructured":"Chi H (2012) Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol 12(5):325\u2013338","journal-title":"Nat Rev Immunol"},{"key":"1341_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104799","volume":"153","author":"D Darif","year":"2021","unstructured":"Darif D, Hammi I, Kihel A, El Idrissi Saik I, Guessous F, Akarid K (2021) The pro-inflammatory cytokines in COVID-19 pathogenesis: what goes wrong? Microb Pathog 153:104799","journal-title":"Microb Pathog"},{"issue":"3","key":"1341_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/vaccines11030699","volume":"11","author":"M Dhawan","year":"2023","unstructured":"Dhawan M, Rabaan AA, Alwarthan S, Alhajri M, Halwani MA, Alshengeti A, Najim MA, Alwashmi ASS, Alshehri AA, Alshamrani SA, AlShehail BM, Garout M, Al-Abdulhadi S, Al-Ahmed SH, Thakur N, Verma G (2023) Regulatory T cells (Tregs) and COVID-19: unveiling the mechanisms, and therapeutic potentialities with a special focus on long COVID. Vaccines 11(3):699","journal-title":"Vaccines"},{"issue":"19","key":"1341_CR9","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.3390\/ijms20194962","volume":"20","author":"C Di Dedda","year":"2019","unstructured":"Di Dedda C, Vignali D, Piemonti L, Monti P (2019) Pharmacological targeting of GLUT1 to control autoreactive T cell responses. Int J Mol Sci 20(19):4962","journal-title":"Int J Mol Sci"},{"key":"1341_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112230","volume":"144","author":"O Kamyshnyi","year":"2021","unstructured":"Kamyshnyi O, Matskevych V, Lenchuk T, Strilbytska O, Storey K, Lushchak O (2021) Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential. Biomed Pharmacother 144:112230","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"1341_CR11","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1084\/jem.20161855","volume":"214","author":"PWF Karmaus","year":"2017","unstructured":"Karmaus PWF, Herrada AA, Guy C, Neale G, Dhungana Y, Long L, Vogel P, Avila J, Clish CB, Chi H (2017) Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF-mediated myelopoiesis. J Exp Med 214(9):2629\u20132647","journal-title":"J Exp Med"},{"issue":"9","key":"1341_CR12","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00424-020-02416-y","volume":"472","author":"F Lang","year":"2020","unstructured":"Lang F, Singh Y, Salker MS, Ma K, Pandyra AA, Lang PA, Lang KS (2020) Glucose transport in lymphocytes. Pflugers Arch 472(9):1401\u20131406","journal-title":"Pflugers Arch"},{"key":"1341_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.coi.2017.04.004","volume":"46","author":"EH Ma","year":"2017","unstructured":"Ma EH, Poffenberger MC, Wong AH, Jones RG (2017) The role of AMPK in T cell metabolism and function. Curr Opin Immunol 46:45\u201352","journal-title":"Curr Opin Immunol"},{"key":"1341_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.774103","volume":"12","author":"S Mafi","year":"2021","unstructured":"Mafi S, Mansoori B, Taeb S, Sadeghi H, Abbasi R, Cho WC, Rostamzadeh D (2021) mTOR-mediated regulation of immune responses in cancer and tumor microenvironment. Front Immunol 12:774103","journal-title":"Front Immunol"},{"issue":"1","key":"1341_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12941-021-00438-7","volume":"20","author":"SI Mallah","year":"2021","unstructured":"Mallah SI, Ghorab OK, Al-Salmi S, Abdellatif OS, Tharmaratnam T, Iskandar MA, Sefen JAN, Sidhu P, Atallah B, El-Lababidi R, Al-Qahtani M (2021) COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob 20(1):35","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"5","key":"1341_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5455\/medarh.2022.76.329-332","volume":"76","author":"P Petakh","year":"2022","unstructured":"Petakh P, Griga V, Mohammed IB, Loshak K, Poliak I, Kamyshnyiy A (2022a) Effects of metformin, insulin on hematological parameters of COVID-19 patients with type 2 diabetes. Med Arch 76(5):329\u2013332","journal-title":"Med Arch"},{"issue":"6","key":"1341_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.5603\/DK.a2022.0055","volume":"11","author":"P Petakh","year":"2022","unstructured":"Petakh P, Isevych V, Mohammed I, Loshak K, Poliak I, Kamyshnyiy A (2022b) Association between use of metformin and insulin with hematological parameters in COVID-19 patients with type 2 diabetes: a single center, cross-sectional study. Clin Diabetol 11(6):432\u2013433","journal-title":"Clin Diabetol"},{"issue":"3","key":"1341_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/v14030477","volume":"14","author":"P Petakh","year":"2022","unstructured":"Petakh P, Kamyshna I, Nykyforuk A, Yao R, Imbery JF, Oksenych V, Korda M, Kamyshnyi A (2022c) Immunoregulatory intestinal microbiota and COVID-19 in patients with type two diabetes: a double-edged sword. J Viruses 14(3):477","journal-title":"J Viruses"},{"issue":"6","key":"1341_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/ph16060904","volume":"16","author":"P Petakh","year":"2023","unstructured":"Petakh P, Kamyshna I, Oksenych V, Kainov D, Kamyshnyi A (2023a) Metformin therapy changes gut microbiota alpha-diversity in COVID-19 patients with type 2 diabetes: the role of SARS-CoV-2 variants and antibiotic treatment. Pharmaceuticals (basel) 16(6):904","journal-title":"Pharmaceuticals (basel)"},{"key":"1341_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1142578","author":"P Petakh","year":"2023","unstructured":"Petakh P, Kobyliak N, Kamyshnyi A (2023b) Gut microbiota in patients with COVID-19 and type 2 diabetes: a culture-based method. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2023.1142578","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1341_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.15407\/fz69.01.035","volume":"69","author":"P Petakh","year":"2023","unstructured":"Petakh P, Loshak K, Kamyshnyi A (2023c) Hematological features of patients with type 2 diabetes depending on the variant of SARS-COV-2. Fiziolohichny\u012d Zhurnal 69(1):35\u201342","journal-title":"Fiziolohichny\u012d Zhurnal"},{"key":"1341_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114892","volume":"163","author":"P Petakh","year":"2023","unstructured":"Petakh P, Oksenych V, Kamyshnyi A (2023d) The F\/B ratio as a biomarker for inflammation in COVID-19 and T2D: impact of metformin. Biomed Pharmacother 163:114892","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1341_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","volume":"29","author":"CD Russell","year":"2023","unstructured":"Russell CD, Lone NI, Baillie JK (2023) Comorbidities, multimorbidity and COVID-19. Nat Med 29(2):334\u2013343","journal-title":"Nat Med"},{"issue":"7","key":"1341_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","volume":"89","author":"A Salminen","year":"2011","unstructured":"Salminen A, Hyttinen JM, Kaarniranta K (2011) AMP-activated protein kinase inhibits NF-\u03baB signaling and inflammation: impact on healthspan and lifespan. J Mol Med (berl) 89(7):667\u2013676","journal-title":"J Mol Med (berl)"},{"key":"1341_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fcell.2018.00122","volume":"6","author":"RJ Salmond","year":"2018","unstructured":"Salmond RJ (2018) mTOR regulation of glycolytic metabolism in T cells. Front Cell Dev Biol 6:122","journal-title":"Front Cell Dev Biol"},{"key":"1341_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113089","volume":"151","author":"P Sharma","year":"2022","unstructured":"Sharma P, Behl T, Sharma N, Singh S, Grewal AS, Albarrati A, Albratty M, Meraya AM, Bungau S (2022) COVID-19 and diabetes: association intensify risk factors for morbidity and mortality. Biomed Pharmacother 151:113089","journal-title":"Biomed Pharmacother"},{"key":"1341_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2020.100316","volume":"22","author":"E Shrestha","year":"2021","unstructured":"Shrestha E, Charkviani M, Musurakis C, Kansakar AR, Devkota A, Banjade R, Pudasainee P, Chitrakar S, Sharma A, Sous M, Padhamanbhan S, Friedman HJ, Nava GR (2021) Type 2 diabetes is associated with increased risk of critical respiratory illness in patients COVID-19 in a community hospital. Obes Med 22:100316","journal-title":"Obes Med"},{"key":"1341_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958430","author":"A Starosz","year":"2022","unstructured":"Starosz A, Jamio\u0142kowska-Sztabkowska M, G\u0142owi\u0144ska-Olszewska B, Moniuszko M, Bossowski A, Grubczak K (2022) Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.958430","journal-title":"Front Immunol"},{"issue":"Suppl 2","key":"1341_CR29","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.2337\/dc09-S318","volume":"32","author":"SG Swinnen","year":"2009","unstructured":"Swinnen SG, Hoekstra JB, DeVries JH (2009) Insulin therapy for type 2 diabetes. Diabetes Care 32(Suppl 2):S253-259","journal-title":"Diabetes Care"},{"issue":"23","key":"1341_CR30","doi-asserted-by":"publisher","first-page":"13068","DOI":"10.3390\/ijms222313068","volume":"22","author":"G Tulipano","year":"2021","unstructured":"Tulipano G (2021) Integrated or independent actions of metformin in target tissues underlying its current use and new possible applications in the endocrine and metabolic disorder area. Int J Mol Sci 22(23):13068","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1341_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/pathogens12020321","volume":"12","author":"L Wang","year":"2023","unstructured":"Wang L, Peng HY, Pham A, Villazana E, Ballard DJ, Das JK, Kumar A, Xiong X, Song J (2023) T cell response to SARS-CoV-2 coinfection and comorbidities. Pathogens 12(2):321","journal-title":"Pathogens"},{"issue":"8","key":"1341_CR32","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108(8):1167\u20131174","journal-title":"J Clin Invest"},{"issue":"3","key":"1341_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1042\/BJ20071084","volume":"411","author":"QL Zhou","year":"2008","unstructured":"Zhou QL, Jiang ZY, Holik J, Chawla A, Hagan GN, Leszyk J, Czech MP (2008) Akt substrate TBC1D1 regulates GLUT1 expression through the mTOR pathway in 3T3-L1 adipocytes. Biochem J 411(3):647\u2013655","journal-title":"Biochem J"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01341-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01341-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01341-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T02:36:55Z","timestamp":1709347015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01341-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1341"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01341-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"15 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}